Then, we performed in vivo IPITT and GSIS assays, and the results showed that insulin resistance was decreased in the oe-circGlis3-treated Leprdb/db mice (Fig. 4p) and that oe-circGlis3 treatment enhanced insulin secretion (Fig. 4q). The gene discussed is INS; the disease is Insulin resistance.